Home

Merck & Co (MRK)

100.30
+1.29 (1.30%)
NYSE · Last Trade: Dec 14th, 11:55 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026fool.com
They could grow into their valuation over the next few years.
Via The Motley Fool · December 12, 2025
Great Rotation: Tech Exodus Fuels Dow's Record Run While Nasdaq Struggles
As of December 12, 2025, the financial markets are witnessing a significant "Great Rotation," a pronounced shift of capital from high-growth technology and Artificial Intelligence (AI) stocks to more traditional value sectors and defensive equities. This ongoing recalibration reflects evolving macroeconomic conditions, a reassessment of risk appetite, and a growing
Via MarketMinute · December 12, 2025
The Green Revolution in Silicon: Semiconductor Manufacturing Embraces Sustainability
The semiconductor industry, the foundational bedrock of our digital world and the engine powering the explosive growth of artificial intelligence, is undergoing a profound transformation. Driven by escalating environmental concerns, stringent regulatory demands, and a heightened sense of corporate responsibility, chip manufacturers are increasingly prioritizing energy efficiency and sustainable practices in every facet of chip [...]
Via TokenRing AI · December 12, 2025
2 Mega-Cap Stocks with Exciting Potential and 1 We Ignore
Megacap stocks are behemoths that set the tone for their industries, and their massive scale typically leads to wide moats. However, the downside is that most have already exploited their existing market opportunities and must invest heavily to expand further, a risky proposition.
Via StockStory · December 11, 2025
Dividend Stocks for 2026: Where to Invest as the Market Coolsmarketbeat.com
Via MarketBeat · December 10, 2025
2 Pharmaceutical Stocks to Buy at a Discountfool.com
Investors are currently so focused on one type of drug that even good companies are being left on the sidelines.
Via The Motley Fool · December 10, 2025
Healthcare Sector Falters: S&P 500's Biggest Loser Amid Broader Market Caution
New York, NY – December 9, 2025 – The S&P 500 Healthcare sector found itself in a precarious position today, emerging as the biggest underperformer among its peers. While the broader S&P 500 index largely treaded water, the healthcare segment registered a notable decline of 0.5%, extending a three-day
Via MarketMinute · December 9, 2025
Explore the top gainers and losers within the S&P500 index in today's session.chartmill.com
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Tuesday as we examine the latest happenings in today's session.
Via Chartmill · December 9, 2025
Here's 1 Major Catalyst Behind Merck Stock's Recent 3.8% Bumpfool.com
The company is finding ways to overcome the headwinds it will encounter in the medium term.
Via The Motley Fool · December 9, 2025
1 Major Factor Behind the Healthcare Sector's Recent Surgefool.com
Blockbuster drugs are a major driver of the growth of healthcare stocks.
Via The Motley Fool · December 9, 2025
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?fool.com
With yields between 3.4% and 6.8%, you'll need to think carefully about the highest yields in the Dow before you buy them.
Via The Motley Fool · December 7, 2025
Merck's Stock is Suddenly Soaring, but Is the Struggling Healthcare Giant a Buy?fool.com
After a long hiatus, why are the bulls so willing to buy in now?
Via The Motley Fool · December 7, 2025
Do These 3 Healthcare Stocks Need a Checkup?fool.com
These three drugmakers are all well off their recent highs. Is this a sign of opportunity or risk?
Via The Motley Fool · December 5, 2025
Trading Near Its 52-Week Low, Is Summit Therapeutics a Good Stock to Buy Right Now?fool.com
The healthcare stock could skyrocket if ivonescimab obtains approval from regulators, but there's still plenty of risk here.
Via The Motley Fool · December 5, 2025
Is This Pharmaceutical Giant a Buy After a Major Acquisition?fool.com
The rebound is well underway.
Via The Motley Fool · December 5, 2025
These Are the 3 Hottest Stocks in the S&P 500 Heading Into the New Year. Should You Invest in Them?fool.com
After tepid performances throughout most of 2025, these stocks are showing some upward momentum.
Via The Motley Fool · December 5, 2025
With Netflix's 10-for-1 Stock Split Complete, Here Are 3 Growth Stocks to Buy in December That Could Issue Stock Splits in 2026fool.com
Surging stock prices and earnings growth potential make Meta Platforms, ASML, and Eli Lilly ripe for stock splits in the new year.
Via The Motley Fool · December 5, 2025
3 Top ETFs I Plan to Pile Into in December to Boost My Passive Income in 2026fool.com
These ETFs can provide me with lots of passive income.
Via The Motley Fool · December 4, 2025
Global Prescription Drug Market Poised for Trillion-Dollar Surge by 2035
The global prescription drugs market is on the cusp of a significant expansion, with recent market reviews and forecasts projecting a robust growth trajectory through 2035. This anticipated surge, driven by an aging global population, the rising prevalence of chronic diseases, and relentless innovation in pharmaceutical research and development, signals
Via MarketMinute · December 3, 2025
Wall Street's Tentative Triumph: Dow, S&P 500, Nasdaq Edge Higher Amidst Shifting Tides
Wall Street has recently concluded a tumultuous yet ultimately resilient period, with the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite all managing to edge higher in late November and early December 2025. This cautious comeback signals a complex market sentiment, where investors are meticulously weighing the promise
Via MarketMinute · December 2, 2025
2 Monster Stocks in the Making to Buy and Holdfool.com
There's still time to get in on these rising stars.
Via The Motley Fool · December 2, 2025
1 Value Stock to Target This Week and 2 We Question
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.
Via StockStory · December 1, 2025
Global Markets Brace as Treasury Yields Surge Amidst BOJ Speculation and Risk Aversion
As December 1, 2025, dawns, global financial markets are grappling with a significant uptick in Treasury yields, a movement primarily catalyzed by a substantial sell-off in Japanese government debt and evolving expectations surrounding central bank policies. This surge has immediately cast a shadow of caution and a 'risk-off' sentiment across
Via MarketMinute · December 1, 2025
Treasury Yields Surge Amid Global Shifts and Fiscal Concerns: A Deep Dive into Market Implications
New York, NY – December 1, 2025 – U.S. Treasury yields have experienced a significant climb today, marking a pivotal moment for financial markets. This ascent, driven by a complex interplay of global monetary policy shifts, persistent inflation concerns, and the ever-growing specter of increased government borrowing, has sent immediate ripple
Via MarketMinute · December 1, 2025
These Underrated Companies Could Be "Training-Wheels" Stocks for Long-Term Wealth Buildersfool.com
If you are thinking in decades and not days, this trio of dividend stocks could be the perfect starting point for your fledgling portfolio.
Via The Motley Fool · November 30, 2025